Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

LON/PRTC stock hub

LON/PRTC has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/PRTCis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

309.6M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/PRTC

In the news

Latest news · LON/PRTC

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-30.9

P25 -54.2P50 2.1P75 13.7

ROIC-44.7

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/PRTC market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

175

Groups with data

Currency

USD

Showing 175 of 175 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	56
Employees Change	-34%
Employees Change Percent	-37.78
Enterprise value	GBX 241.4M
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biotechnology
Isin	GB00BY2Z0H74
Last refreshed	2026-05-10
Market cap	GBX 309.6M
Price	GBX 127
Price currency	GBX
Rev Per Employee	61,814.95x
Sector	Healthcare
Sic	2836
Symbol	lon/PRTC
Website	https://www.puretechhealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-26.33%
EV Earnings	-2.96x
EV/FCF	-3.82x
EV/Sales	69.73x
FCF yield	-20.43%
P/B ratio	1.36x
P/S ratio	89.45x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	GBX 3.5M
Net Income	GBX -81.5M
Net Income Growth Years	0%
Pretax Margin	-2,380.9%
Profit Per Employee	GBX -1.5M
ROA	-10.83
Roa5y	-12.32
ROCE	-20.17
ROE	-30.85
Roe5y	-10.87
ROIC	-44.74
Roic5y	-63.74

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	0.11%
Cagr1y	0.95%
Cagr3y	-16.81%
Cagr5y	-19.91%
EPS Growth Years	0
Revenue Growth	-3.5x
Revenue Growth Q	542.71x
Revenue Growth Years	2x
Revenue Growth3 Y	115.12x
Revenue Growth5 Y	-16.87x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	GBX 0.01
Assets	GBX 397.3M
Cash	GBX 214.5M
Current Assets	GBX 252.6M
Current Liabilities	GBX 29.8M
Debt	GBX 151M
Debt Equity	GBX 0.66
Debt FCF	GBX -2.39
Equity	GBX 227.1M
Interest Coverage	-2.15
Liabilities	GBX 170.2M
Long Term Assets	GBX 144.7M
Long Term Liabilities	GBX 140.4M
Net Cash	GBX 63.5M
Net Cash By Market Cap	GBX 20.51
Net Cash Growth	-52.85%
Net Debt Equity	GBX -0.28
Tangible Book Value	GBX 231.4M
Tangible Book Value Per Share	GBX 0.98
WACC	11.6

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.59
Net Working Capital	GBX -6.1M
Quick ratio	6.41
Working Capital	GBX 192.2M
Working Capital Turnover	GBX 0.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	6.38%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	1.15%
1Y total return	0.95%
200-day SMA	127.1
3Y total return	-42.44%
50-day SMA	122.7
50-day SMA vs 200-day SMA	50under200
5Y total return	-67.05%
All Time High	447.7
All Time High Change	-71.59%
All Time High Date	2020-12-29
All Time Low	100.4
All Time Low Change	26.69%
All Time Low Date	2025-04-09
ATR	6.34
Beta	0.79
Beta1y	1.05
Beta2y	0.85
Ch YTD	1.76
High	129.8
High52	148
High52 Date	2025-07-29
High52ch	-14.05%
Low	125
Low52	104.7
Low52 Date	2025-09-18
Low52ch	21.48%
Ma50ch	3.64%
Price vs 200-day SMA	0.12%
RSI	51.24
RSI Monthly	43.07
RSI Weekly	50.26
Sharpe ratio	0.1x
Sortino ratio	0.35
Total Return	6.38%
Tr YTD	1.76
Tr1m	11.97%
Tr1w	-8.36%
Tr3m	0.47%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	GBX -73.2M
Operating margin	-2,114.7

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	157,179,500%
Net Borrowing	-2,625,246.6
Shares Insiders	3.56%
Shares Institutions	75.13%
Shares Out	243,418,190
Shares Qo Q	-1%
Shares Yo Y	-6.38%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	GBX -69.4M
Average Volume	768,846.9x
Bv Per Share	0.98
CAPEX	GBX -4,458
Ch10y	1.15
Ch1m	11.97
Ch1w	-8.36
Ch1y	0.95
Ch3m	0.47
Ch3y	-42.44
Ch5y	-67.05
Ch6m	2.58
Change	-0.63%
Change From Open	-1.64
Close	128
Days Gap	1.03
Depreciation Amortization	2,455,804.9
Dollar Volume	104,499,379.2
Earnings Date	2026-04-29
EBIT	GBX -73.2M
EBITDA	GBX -70.7M
EPS	GBX -0.34
F Score	2
FCF	GBX -63.3M
FCF EV Yield	-26.21x
FCF Per Share	GBX -0.26
Financing CF	-4,701,704
Fiscal Year End	December
Founded	2,015
Income Tax	GBX -625,606
Investing CF	47,022,984
Is Primary Listing	1
Last Earnings Date	2026-04-29
Last Report Date	2025-06-30
Ma150	126.6
Ma150ch	0.44%
Ma20	128.9
Ma20ch	-1.28%
Net CF	-20,931,053
Next Earnings Date	2026-05-28
Open	129.3
Position In Range	45.83
Ppne	9,766,005.4
Price Date	2026-05-08
Ptbv Ratio	1.34
Relative Volume	1.11x
Revenue	3,461,637x
SBC By Revenue	176.48x
Share Based Comp	6,108,946
Tax By Revenue	-18.07x
Tr6m	2.58%
Volume	821,536

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/PRTC pay a dividend?

Capital-return profile for this ticker.

Performance

LON/PRTC stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/PRTC?

Insider, institutional, and short-interest positioning.

Institutional ownership

+75.1%

Share of float held by funds and institutions

Insider ownership

+3.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-6.4%

Negative means the company is buying back shares.

Technical

LON/PRTC momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

51.2

Neutral momentum band

Price vs 200-day MA

+0.1%

50/200-day relationship not available

Beta (5Y)

0.79

Less volatile than the market

Sharpe ratio

0.10

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/PRTC

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/PRTC stock rating?

lon/PRTC is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/PRTC analysis?

The full report lives at /stocks/lon/PRTC/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/PRTC?

The latest report frames lon/PRTC around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/PRTC page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.